ARP101 inhibits α-MSH-stimulated melanogenesis by regulation of autophagy in melanocytes

FEBS Letters

Volumn 587, Issue 24, 2013, Pages 3955-3960

  Kim, Eun Sung ^a   Jo, Yoon Kyung ^a   Park, So Jung ^a   Chang, Huikyoung ^b   Shin, Ji Hyun ^a   Choi, Eun Sun ^a   Kim, Jun Bum ^a   Seok, Su Hyeon ^a   Kim, Jae Sung ^c   Oh, Jeong Su ^d   Kim, Myoung Hwan ^e   Lee, Eunjoo H ^a   Cho, Dong Hyung ^a  

^a Kyung Hee University   (South Korea)

^b AmorePacific Corporation   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

ARP101; Autophagy; Melanocytes; Melanogenesis

Indexed keywords

ACTINONIN; ALPHA INTERMEDIN; ARBUTIN; ARP 101; GELATINASE A; MELANIN; MONOPHENOL MONOOXYGENASE; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; AUTOPHAGY; CELL FUNCTION; CELL IMMORTALIZATION; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME INHIBITION; ENZYME SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MELANOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SKIN PIGMENTATION;

EID: 84888644428     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.10.027     Document Type: Article

References (32)

1. R.A. Spritz, and V.J. Hearing Jr. Genetic disorders of pigmentation Adv. Hum. Genet. 22 1994 1 45
2. S. Briganti, E. Camera, and M. Picardo Chemical and instrumental approaches to treat hyperpigmentation Pigment Cell Res. 16 2003 101 110
3. P.C. Eves, S. MacNeil, and J.W. Haycock Alpha-Melanocyte stimulating hormone, inflammation and human melanoma Peptides 27 2006 444 452
4. Y. Yamaguchi, M. Brenner, and V.J. Hearing The regulation of skin pigmentation J. Biol. Chem. 282 2007 27557 27561
5. A.K. Ganesan, H. Ho, B. Bodemann, S. Petersen, and J. Aruri Genome-wide siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells PLoS Genet. 4 2008 e1000298
6. H. Ho, and A.K. Ganesan The pleiotropic roles of autophagy regulators in melanogenesis Pigment Cell Melanoma. Res. 24 2011 595 604
7. D.J. Klionsky, F.C. Abdalla, H. Abeliovich, R.T. Abraham, and A. Acevedo-Arozena Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy 8 2012 445 544
8. S. Sridhar, Y. Botbol, F. Macian, and A.M. Cuervo Autophagy and disease: always two sides to a problem J. Pathol. 226 2012 255 273
9. N. Mizushima, B. Levine, A.M. Cuervo, and D.J. Klionsky Autophagy fights disease through cellular self-digestion Nature 451 2008 1069 1075
10. P. Lista, E. Straface, S. Brunelleschi, F. Franconi, and W. Malorni On the role of autophagy in human diseases: a gender perspective J. Cell Mol. Med. 15 2011 1443 1457
11. R.A. Hanna, M.N. Quinsay, A.M. Orogo, K. Giang, and S. Rikka Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy J. Biol. Chem. 287 2012 19094 19104
12. D. Murase, A. Hachiya, K. Takano, R. Hicks, and M.O. Visscher Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes J. Invest. Dermatol. 2013 10.1038/jid.2013.165
13. M.A. Santos, S.M. Marques, T. Tuccinardi, P. Carelli, and L. Panelli Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors Bioorg. Med. Chem. 14 2006 7539 7550
14. Y.K. Jo, S.J. Park, J.H. Shin, Y. Kim, and J.J. Hwang ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells Biochem. Biophys. Res. Commun. 404 2011 1039 1043
15. A. Kuma, M. Hatano, M. Matsui, A. Yamamoto, and H. Nakaya The role of autophagy during the early neonatal starvation period Nature 432 2004 1032 1036
16. K. Fujiwara, S. Daido, A. Yamamoto, R. Kobayashi, and T. Yokoyama Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy J. Biol. Chem. 283 2008 388 397
17. T. Tsuboi, H. Kondoh, J. Hiratsuka, and Y. Mishima Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma Pigment Cell Res. 11 1998 275 282
18. J.G. van den Boorn, D.I. Picavet, P.F. van Swieten, H.A. van Veen, and D. Konijnenberg Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy J. Invest. Dermatol. 131 2011 1240 1251
19. D.C. Bennett, and M.L. Lamoreux The color loci of mice - a genetic century Pigment Cell Res. 16 2003 333 344
20. T.S. Chang An updated review of tyrosinase inhibitors Int. J. Mol. Sci. 10 2009 2440 2475
21. T. Grimm, A. Schäfer, and P. Högger Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol) Free Radic. Biol. Med. 36 2004 811 822
22. M.D. Matchett, S.L. MacKinnon, M.I. Sweeney, K.T. Gottschall-Pass, and R.A. Hurta Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells Biochem. Cell Biol. 83 2005 637 643
23. H.S. Cho, D.H. Kwak, I.S. Choi, H.K. Park, and S.J. Kang Inhibitory effect of proanthocyanidin on ultraviolet B irradiation-induced melanogenesis J. Toxicol. Environ. Health 72 2009 1475 1483
24. C. Dessinioti, A.J. Stratigos, D. Rigopoulos, and A.D. Katsambas A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes Exp. Dermatol. 18 2009 741 749
25. J. Vachtenheim, and J. Borovanský "Transcription physiology" of pigment formation in melanocytes: central role of MITF Exp. Dermatol. 19 2010 617 627
26. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, and J. Wang-Rodriguez Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res. 61 2001 5974 5978
27. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
28. U.B. Hofmann, J.R. Westphal, A.J. Zendman, J.C. Becker, and D.J. Ruiter Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression J. Pathol. 191 2000 245 256
29. B. Schmalfeldt, D. Prechtel, K. Härting, K. Späthe, and S. Rutke Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer Clin. Cancer Res. 7 2001 2396 2404
30. S. Zucker, and J. Cao Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time? Cancer Biol. Ther. 8 2009 2371 2373
31. H. Ho, R. Kapadia, S. Al-Tahan, S. Ahmad, and A.K. Ganesan WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition J. Biol. Chem. 286 2011 12509 12523
32. Y.S. Hah, H.Y. Cho, T.Y. Lim, D.H. Park, and H.M. Kim Induction of melanogenesis by rapamycin in human MNT-1 melanoma cells Ann. Dermatol. 24 2012 151 157